IntroductionHemodialysis access-induced distal ischemia (HAIDI) has been reported to have an incidence of 1%-8%. 1 However, this is based on referred cases requiring surgical treatment. Its true frequency is dependent upon the symptom threshold used to qualify for the diagnosis. Systematic patient evaluation has shown that mild to moderate symptoms occur much more frequently. 2 The reported incidence relates to the upper extremity and is the topic of this review. Access-related distal ischemia can also involve the lower extremity with serious consequences. 3,4 An understanding of HAIDI and the appropriate role of the interventional nephrologist in its management is important when patients present with symptoms suggestive of HAIDI. Herein, the pathophysiology of the syndrome is discussed followed by recommendations for its diagnosis and management and the basis for the recommendations. These recommendations
ASDIN white paper: Assessment and management of hemodialysis accessinduced distal ischemia by interventional nephrologists AbstractAlthough not common, hemodialysis access-induced distal ischemia is a serious condition resulting in significant hemodialysis patient morbidity. Patients with signs and symptoms suggestive of hand ischemia frequently present to the general and interventional nephrologist for evaluation. In order to care for these cases, it is necessary to understand this syndrome and its management. Most cases can be managed conservatively without intervention. Some cases requiring intervention may be treated using techniques within the scope of practice of the interventional nephrologists while other cases require vascular surgery. In order for the interventional nephrologists to evaluate and manage these cases in a timely and appropriate manner, practice guidelines are presented.